Contributing Faculty

The following individuals contributed to the My IFI website.

4-Alexander

Barbara D. Alexander, MD
Professor of Medicine and Pathology
Division of Infectious Diseases
Duke University
Durham, NC

5-Andes

David R. Andes, MD
William A. Craig Professor of Infectious Diseases
Chief, Division of Infectious Diseases
Director, Wisconsin Antimicrobial Discovery and Development Center
Departments of Medicine, Microbiology, and Immunology
School of Medicine and Public Health and School of Pharmacy
Madison, WI

6-Dold

Andrew B. Dold, DO
Infectious Diseases Consultant
Northeast Georgia Medical Center
Gainesville, GA

7-Frattini

Mark G. Frattini, MD, PhD
Associate Professor of Medicine and Experimental Therapeutics
Division of Hematology/Oncology
Director of Research, Hematologic Malignancies
Department of Medicine
Columbia University Medical Center
New York, NY

8-Gregory

Stephanie J. Gregory, FNP-C, BMTCN
Nurse Practitioner
Grafenwöhr, Germany

10-Kiser

Tyree H. Kiser, PharmD
Professor
Department of Clinical Pharmacy
University of Colorado
Clinical Pharmacy Specialist
Department of Pharmacy
University of Colorado Hospital
Aurora, CO

11-Nailor

Michael D. Nailor, PharmD
Clinical Specialist–Infectious Diseases
Department of Pharmacy Services
St. Joseph's Hospital and Medical Center
Phoenix, AZ

12-Penza

Sam L. Penza, MD
Professor of Clinical Internal Medicine
Division of Hematology
The Ohio State University Wexner
Medical Center
Medical Director of Quality for The James Cancer Hospital
The Arthur G. James Cancer Center Hospital and Richard D. Solove Research Institute
Columbus, OH

13-Perissionitti

Anthony J. Perissinotti, PharmD
Hematology Clinical Pharmacist Specialist
Department of Pharmacy
University of Michigan
Ann Arbor, MI

14-Skinner

Nancy E. Skinner, RN-BC, CCM, ACM-RN, CMCN
Founding Member
National Transitions of Care Coalition
Adjunct Faculty, Retired
College of Nursing and Health Professions
University of Southern Indiana
Evansville, IN

15-Spec

Andrej Spec, MD, MSCI
Assistant Professor of Medicine
Associate Director of Infectious Disease
Clinical Research Unit
Washington University
St. Louis, MO

Note that the initial content of this website was based on the proceedings of a multidisciplinary consensus panel meeting held in August 2016. This meeting was supported by Astellas. Updates to the site are made periodically.

Also note that the listing of faculty affiliations does not imply endorsement of this content by these institutions. Please review the faculty disclosures, listed below.

Faculty Disclosures

Each faculty member has entered into a written agreement and has received compensation from Astellas Pharma US, Inc., for his or her work in the development of this initiative. Additional disclosures (as of April 2019) are noted below.

Dr Alexander serves or has served as a consultant for Astellas Pharma US, Inc.; Cidara Therapeutics, Inc.; Shire plc; and SCYNEXIS, Inc. She receives or has received research support from Astellas Pharma US, Inc.; Gilead Sciences, Inc.; Shire plc; SCYNEXIS, Inc.; and Viamet Pharmaceuticals, Inc.

Dr Andes serves or has served as a consultant for Astellas Pharma US, Inc.; Meiji Holdings Co., Ltd.; Theravance Biopharma, Inc.; and Zavante Therapeutics, Inc. He receives or has received research support from Actelion Pharmaceuticals US, Inc.; Astellas Pharma US, Inc.; Cidara Therapeutics, Inc.; Paratek Pharmaceuticals, Inc.; SCYNEXIS, Inc.; and Theravance Biopharma, Inc.

Dr Dold serves or has served on speaker bureaus for Allergan plc; Astellas Pharma US, Inc.; The Medicines Company; Merck & Co., Inc.; Oxford Labs; and Pfizer Inc.

Dr Frattini serves or has served as a consultant for Juno Therapeutics and Merck & Co., Inc.

Mrs Gregory has served as a consultant for Astellas Pharma US, Inc. and as a member of speaker bureaus for Celgene Corporation and Midatech Pharma.

Dr Kiser serves or has served as a consultant and member of a speaker bureau for Astellas Pharma US, Inc. He receives or has received research support from Allergan plc.

Dr Nailor serves or has served as a consultant for Astellas Pharma US, Inc. He receives or has received research support from Allergan plc and Merck & Co., Inc.

Dr Penza serves or has served as a consultant for Astellas Pharma US, Inc. and Merck & Co., Inc. He serves or has served on a speaker bureau for Merck & Co., Inc.

Dr Perissinotti serves or has served as a consultant for Astellas Pharma US, Inc. and Servier Pharmaceuticals.

Ms Skinner serves or has served as a consultant for Astellas Pharma US, Inc. (on an advisory board); AstraZeneca; Genentech, a member of the Roche Group; The Medicines Company (on an advisory board); Novartis Pharmaceuticals Corporation; and Pfizer Inc. She serves or has served on speaker bureaus for Daiichi Sankyo Co., Ltd. and Novartis Pharmaceuticals Corporation.

Dr Spec serves or has served as a consultant for Astellas Pharma US, Inc.; MiraVista Diagnostics; and SCYNEXIS, Inc. He receives or has received research support from Astellas Pharma US, Inc.